Steven Cohen's position in Janux Therapeutics is currently worth $51.3M. That's 0.12% of their equity portfolio (209th largest holding). The investor owns 3.76% of the outstanding Janux Therapeutics stock. The first Janux Therapeutics trade was made in Q2 2024. Since then Steven Cohen bought shares three more times and sold shares on one occasions. The investor's estimated purchase price is $68.2M, resulting in a loss of 25%.